Seeing in person how an ongoing project in the Faroe Islands will lead to genomic findings and improve health: medium.com/variantbio/a-v…

Wonderful to be in conversation with bioethicists from around the world when presenting about Variant Bio’s approach to genomic research and drug discovery at this week’s World Congress of Bioethics in Doha, Qatar #WCB2024

It is an honor to see a case study from Variant Bio and research on gout carried out in French Polynesia featured in the latest report from Public Policy Projects. Read more in the press release and download the full report here 👉 lnkd.in/djPv2Aun

Isabella has been a phenomenal member of the Variant Bio team during her time as a Standley Fellow. This very exciting collaboration in Indonesia wouldn't have been possible without her!

Huge thanks to Maui Hudson for the inspiring and thought-provoking talk he gave to the team at Variant Bio!

This week Jaye Moors presented on behalf of Variant Bio at the PRECISE-IHCC Conference in Singapore, where she had a great time meeting up with long-time collaborators from the Mochtar Riady Institute for Nanotechnology in Indonesia!

How Variant Bio is leveraging multi-omics data from studies with diverse populations to boost drug discovery and development: medium.com/variantbio/the…

Last week, Sarah LeBaron von Baeyer from Variant Bio gave a plenary talk at the BIO2024 Conference at the University of Pretoria Future Africa campus in Pretoria, South Africa based on our recent Commentary in Cell. In case you missed it, read the full publication here: sciencedirect.com/science/articl…

Congratulations to Olivia Gray from Variant Bio and all of our colleagues who received an abstract award ASHG last week! #ASHG2024

We recently met with partners and community leaders in New Caledonia to conclude one of Variant Bio’s largest studies to date: medium.com/variantbio/con…

How Variant Bio and the Pukapuka Community Group returned group-level results from a collaborative genomic research study in Auckland: medium.com/variantbio/ret…

Excited to share that Variant Bio is partnering with Novo Nordisk to identify metabolic disease targets. This gives us the opportunity to translate more findings into treatments that will have a real world impact for patients. medium.com/variantbio/var…

The collaboration between Variant Bio and Novo Nordisk will trigger our long term benefit sharing program for the first time! Read about it in the NYT. nytimes.com/2025/01/07/hea…

Our advisor Dr./Prof. Keolu Fox sharing news of Variant Bio's ground-breaking partnership with Novo Nordisk during a keynote at the Pacific Symposium on Biocomputing (PSB) 2025 in Hawaii this week

I will be at #JPM25 next week - don't hesitate to reach out if you'd like to connect. Looking forward to an exciting week!

Listen to Seattle's NPR coverage of Variant Bio's new partnership with Novo Nordisk and our approach to making human genomic research and drug discovery both more ethical and equitable: kuow.org/stories/seattl…

Variant Bio visits long-term partners in the Faroe Islands to celebrate the end of participant recruitment and kick off data generation together: medium.com/variantbio/cel…

Honored for Variant Bio to have been featured by SoftBank in their Sōzō Insights series.